Somkin C P, Hiatt R A, Hurley L B, Gruskin E, Ackerson L, Larson P
Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, Oakland, USA.
Arch Intern Med. 1997;157(15):1658-64.
We evaluated the effectiveness of 2 reminder interventions to increase the use of screening mammograms and Papanicolaou (Pap) smears among female members of a large health maintenance organization.
Seven thousand seventy-seven female health maintenance organization members (aged 50-74 years with no prior mammogram in the previous 30 months or aged 20-64 years with no prior Pap smear in the previous 36 months) were randomized to receive one of the following: a letter inviting them to make an appointment for a mammogram or a Pap smear; in addition to the letter, a reminder manually placed in the patient's medical chart alerting providers of that member's need for screening; or their usual care.
Compared with women who did not receive the reminder letter, women who did receive the letter were more likely to obtain mammograms (16.0% vs 25.5%, respectively; P < .001) or Pap smears (9.1% vs 19.5%, respectively; P < .001) in the 6 months following their entry into the study. Compared with women who received only the reminder letter, women who received a reminder letter and had a reminder placed in their medical chart were more likely to obtain mammograms (26.5% vs 30.9%, respectively; P = .02) and marginally more likely to receive Pap smears (19.5% vs 22.8%, respectively; P = .04).
We recommend the use of patient reminder letters as a first step in a mammography or Pap smear screening outreach program. Further research is needed to evaluate a cost-effective provider reminder system and additional outreach strategies directed to women who do not use health care services.
我们评估了两种提醒干预措施在提高大型健康维护组织女性成员乳腺钼靶筛查和巴氏涂片检查使用率方面的有效性。
7077名健康维护组织女性成员(年龄在50 - 74岁且在过去30个月内未进行过乳腺钼靶检查,或年龄在20 - 64岁且在过去36个月内未进行过巴氏涂片检查)被随机分为以下几组:收到邀请预约乳腺钼靶或巴氏涂片检查的信件;除信件外,在患者病历中手动放置提醒,告知医护人员该成员需要进行筛查;或接受常规护理。
与未收到提醒信的女性相比,收到信件的女性在进入研究后的6个月内更有可能进行乳腺钼靶检查(分别为16.0%对25.5%;P <.001)或巴氏涂片检查(分别为9.1%对19.5%;P <.001)。与仅收到提醒信的女性相比,收到提醒信且病历中有提醒的女性更有可能进行乳腺钼靶检查(分别为26.5%对30.9%;P =.02),进行巴氏涂片检查的可能性略高(分别为19.5%对22.8%;P =.04)。
我们建议将患者提醒信作为乳腺钼靶或巴氏涂片筛查推广项目的第一步。需要进一步研究来评估具有成本效益的医护人员提醒系统以及针对不使用医疗服务的女性的其他推广策略。